MedTrace Logo

Amino Acid Tracer (FACBC) Positron Emission Tomography for Lung Nodule

NCT01502670 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2013-11-19

No results posted yet for this study

Summary

This study will look at how the \[18\]FACBC goes into the lung nodules. This will hopefully lead to the development of better imaging techniques to look at lung nodules. \[18\]FACBC is not approved by the FDA (Food and Drug Administration). This study will help to determine if it should be approved by the FDA.

Conditions

Interventions

DRUG

18F-FACBC Radiotracer

Test radiotracer uptake in lung nodule

Sponsors & Collaborators

  • Nihon Medi-Physics Co., Ltd.

    collaborator INDUSTRY

  • Emory University

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2012-06-30
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01502670 on ClinicalTrials.gov